Trial Profile
A study evaluating safety and efficacy of Ustekinumab on psoriasis patients over five years.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2017
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriasis; Psoriatic arthritis
- Focus Adverse reactions; Therapeutic Use
- 08 Jun 2017 New trial record